Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Aviva's HALO Position: Q1 2026 in Review
Aviva sold out of Halozyme (HALO) in Q1 2026, closing a stake of 11,674 shares — an estimated $786K sold.
Aviva first reported a position in HALO in Q1 2020 and held it in 16 quarters. The position peaked at $6.57M in Q4 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Aviva reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
- Aviva sold 11,674 Halozyme shares in Q1 2026, an estimated $786K.
- Aviva first reported a position in Halozyme in Q1 2020 and held it in 16 quarters.
- Aviva's Halozyme position peaked at $6.57M in Q4 2024.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.